G6PD and acute myeloid leukemia: They showed that AML cell lines and primary AML blasts undergo apoptosis upon 6-aminonicotinamide treatment—a potent inhibitor of G6P dehydrogenase (G6PD)—whereas normal hematopoietic progenitor cells were unaffected.